Colorado State University, Dept. of Health and Exercise Science
Fort Collins, Colorado, 80523-1582, United States
NCT Number: NCT01702025
In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1 / Phase 2
Fort Collins, Colorado, 80523-1582, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Yellow corn meal in gel capsules
Other names: Yellow corn meal
National Drug Code (NDC) 0143-1020-01
Other names: Theophylline
NDC 0781-1072-01
Other names: Neptazane
NDC 0143-1020-01 and NDC 0781-1072-01
Other names: Theophylline + Neptazane
Time frame: The exercise trial will begin within 5 hours of exposure to either normoxia or hypoxia
After exercising on a stationary cycle ergometer for 30 minutes at a resistance of 100 watts, research participants will complete an exercise time trial. The time taken to cycle a distance equivalent to 7.75 miles will be recorded. On a separate day the experiment will be repeated in hypoxia. It is expected that the time taken to cycle a distance equivalent to 7.75 miles will be longer in hypoxia compared to normoxia. One of the goals of this research is to determine if the hypoxia-mediated performance decrement can be decreased with one of our pharmacological interventions.
Colorado State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06345612
Autoimmune Diseases, Behavior
Zabrze, Silesian Voivodeship, Poland
View Trial DetailsNCT07341165
Behavior, Exercise
Louvain-la-Neuve, Belgium
View Trial DetailsNCT01614119
Behavior, Brain Diseases
Grenoble, France
View Trial DetailsNCT06264193
Behavior, Hypoxia
View Trial Details